Notably, this was not only seen in ASCL1+ tumors (for example, SCLC-04, NE score 0.4) but also in the POU2F3+ tumor with a positive NE-score (SCLC-15, NE score 0.26) (Fig. 1c). This evidence concerns the gene POU2F3 and neoplasm.